Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Franzius

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Nuklearmedizin. Nuclear Medicine|May 22, 2008
[Procedure guidelines for MIBG-scintigraphy in children]C Franzius, M Schmidt, B Hero, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2007
The new EANM paediatric dosage cardM Lassmann, L Biassoni, M Monsieurs, et al.
Annals of the New York Academy of Sciences|October 24, 2006
High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel diseaseM Löffler, M Weckesser, C Franzius, et al.
European Journal of Nuclear Medicine|September 28, 2000
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphyC Franzius, J Sciuk, H E Daldrup-Link, et al.
Nuklearmedizin. Nuclear Medicine|January 1, 2000
High-activity samarium-153-EDTMP therapy in unresectable osteosarcomaC Franzius, S Bielack, J Sciuk, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|October 12, 2001
[Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group]C Franzius, M Schulte, A Hillmann, et al.
Nuklearmedizin. Nuclear Medicine|January 19, 2002
High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcomaC Franzius, S Bielack, S Flege, et al.
Nuklearmedizin. Nuclear Medicine|February 16, 2005
Staging in childhood lymphoma: differences between FDG-PET and CTS Hermann, D Wormanns, M Pixberg, et al.
The Thoracic and Cardiovascular Surgeon|April 28, 2006
Mucinous cystadenocarcinoma--an extremely rare tumor in a young patientO Sezer, A Hoffmeier, O Bettendorf, et al.
Nuclear Medicine and Biology|April 11, 2001
Characterization of 3-[123I]iodo-L-alpha-methyl tyrosine ([123I]IMT) transport into human Ewing's sarcoma cells in vitroC Franzius, K Kopka, F van Valen, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Nuklearmedizin. Nuclear Medicine|May 22, 2008
[Procedure guidelines for MIBG-scintigraphy in children]C Franzius, M Schmidt, B Hero, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2007
The new EANM paediatric dosage cardM Lassmann, L Biassoni, M Monsieurs, et al.
Annals of the New York Academy of Sciences|October 24, 2006
High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel diseaseM Löffler, M Weckesser, C Franzius, et al.
European Journal of Nuclear Medicine|September 28, 2000
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphyC Franzius, J Sciuk, H E Daldrup-Link, et al.
Nuklearmedizin. Nuclear Medicine|January 1, 2000
High-activity samarium-153-EDTMP therapy in unresectable osteosarcomaC Franzius, S Bielack, J Sciuk, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|October 12, 2001
[Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group]C Franzius, M Schulte, A Hillmann, et al.
Nuklearmedizin. Nuclear Medicine|January 19, 2002
High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcomaC Franzius, S Bielack, S Flege, et al.
Nuklearmedizin. Nuclear Medicine|February 16, 2005
Staging in childhood lymphoma: differences between FDG-PET and CTS Hermann, D Wormanns, M Pixberg, et al.
The Thoracic and Cardiovascular Surgeon|April 28, 2006
Mucinous cystadenocarcinoma--an extremely rare tumor in a young patientO Sezer, A Hoffmeier, O Bettendorf, et al.
Nuclear Medicine and Biology|April 11, 2001
Characterization of 3-[123I]iodo-L-alpha-methyl tyrosine ([123I]IMT) transport into human Ewing's sarcoma cells in vitroC Franzius, K Kopka, F van Valen, et al.
Pageof 4